JP2008542225A5 - - Google Patents

Download PDF

Info

Publication number
JP2008542225A5
JP2008542225A5 JP2008512772A JP2008512772A JP2008542225A5 JP 2008542225 A5 JP2008542225 A5 JP 2008542225A5 JP 2008512772 A JP2008512772 A JP 2008512772A JP 2008512772 A JP2008512772 A JP 2008512772A JP 2008542225 A5 JP2008542225 A5 JP 2008542225A5
Authority
JP
Japan
Prior art keywords
blue
dental composition
indicator
green
sodium salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008512772A
Other languages
English (en)
Japanese (ja)
Other versions
JP5054002B2 (ja
JP2008542225A (ja
Filing date
Publication date
Priority claimed from EP05011336A external-priority patent/EP1733762A1/en
Application filed filed Critical
Publication of JP2008542225A publication Critical patent/JP2008542225A/ja
Publication of JP2008542225A5 publication Critical patent/JP2008542225A5/ja
Application granted granted Critical
Publication of JP5054002B2 publication Critical patent/JP5054002B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008512772A 2005-05-25 2006-05-24 齲蝕組織を検出する歯科用組成物、検出方法 Expired - Fee Related JP5054002B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05011336A EP1733762A1 (en) 2005-05-25 2005-05-25 Dental composition for detection of carious tissue, detection method
EP05011336.4 2005-05-25
PCT/EP2006/005004 WO2006125650A1 (en) 2005-05-25 2006-05-24 Dental composition for detection of carious tissue, detection method

Publications (3)

Publication Number Publication Date
JP2008542225A JP2008542225A (ja) 2008-11-27
JP2008542225A5 true JP2008542225A5 (enExample) 2009-07-09
JP5054002B2 JP5054002B2 (ja) 2012-10-24

Family

ID=35735006

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008512772A Expired - Fee Related JP5054002B2 (ja) 2005-05-25 2006-05-24 齲蝕組織を検出する歯科用組成物、検出方法

Country Status (8)

Country Link
US (2) US20080241800A1 (enExample)
EP (2) EP1733762A1 (enExample)
JP (1) JP5054002B2 (enExample)
KR (1) KR101260542B1 (enExample)
CN (1) CN101184533B (enExample)
AU (1) AU2006251265B2 (enExample)
CA (1) CA2609044A1 (enExample)
WO (1) WO2006125650A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5366553B2 (ja) 2005-11-09 2013-12-11 クロックス テクノロジーズ インコーポレイテッド 歯のホワイトニング組成物及び方法
US8647119B1 (en) 2006-04-18 2014-02-11 President And Fellows Of Harvard College Methods and kits with fluorescent probes for caries detection
US20100266989A1 (en) 2006-11-09 2010-10-21 Klox Technologies Inc. Teeth whitening compositions and methods
JP5005373B2 (ja) * 2007-02-02 2012-08-22 株式会社ジーシー 齲蝕活性評価用の歯垢染色用組成物
CA2706355C (en) * 2008-02-08 2014-11-18 Colgate-Palmolive Company Oral care product and methods of use and manufacture thereof
WO2010062377A2 (en) 2008-10-31 2010-06-03 Yale University Methods and compositions for the detection and treatment of preeclampsia
NZ592651A (en) 2008-11-07 2013-05-31 Klox Technologies Inc Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin
GB0909206D0 (en) 2009-05-28 2009-07-15 Lux Innovate Ltd Approximal imaging device
PL2453922T3 (pl) 2009-07-17 2018-03-30 Klox Technologies Inc. Przeciwbakteryjna doustna kompozycja
US20130281913A1 (en) 2012-04-20 2013-10-24 Klox Technologies Inc. Biophotonic compositions and methods for providing biophotonic treatment
US11116841B2 (en) 2012-04-20 2021-09-14 Klox Technologies Inc. Biophotonic compositions, kits and methods
EP2895139B1 (en) 2012-09-14 2019-10-23 Bausch Health Companies Inc. Methods for teeth whitening
EP2925275A2 (en) * 2012-11-30 2015-10-07 Rls Global Ab Detection of carious dentin tissue and removal thereof by means of a dental instrument
US20140276354A1 (en) 2013-03-14 2014-09-18 Klox Technologies Inc. Biophotonic materials and uses thereof
HK1219890A1 (zh) 2013-07-03 2017-04-21 广东科洛克生物医药集团有限公司 治疗不癒合伤口的组合物和方法
JP2017509433A (ja) 2014-04-01 2017-04-06 クロックス テクノロジーズ インコーポレイテッドKlox Technologies Inc. 組織充填剤組成物および使用方法
CA3157573C (en) * 2014-04-10 2025-11-18 Yale University METHODS AND COMPOSITIONS FOR DETECTING MISFOLDED PROTEINS
RU2017117187A (ru) 2014-10-31 2018-11-30 Клокс Текнолоджиз Инк. Фотоактивируемые волокна и тканые материалы
EP3658068B1 (en) * 2017-07-25 2025-04-09 Solventum Intellectual Properties Company Water-resistant polymer-based dental articles
CN109987969B (zh) * 2019-04-29 2021-07-06 成都贝施美生物科技有限公司 一种快速浸泡氧化锆义齿染色液

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4167587A (en) * 1977-06-22 1979-09-11 Danforth Richard C Compositions and process for colored liquid food or drink
JPS57175129A (en) * 1981-04-19 1982-10-28 Kyoto Daiichi Kagaku:Kk Composition for testing carious activity
US4980152A (en) * 1987-08-06 1990-12-25 Marion Laboratories Oral preparation
US5154917A (en) * 1990-09-11 1992-10-13 Beecham Inc. Color change mouthrinse
GB2250817A (en) * 1990-12-12 1992-06-17 Naresh Gathani Dental caries diagnostic floss.
US5766012A (en) * 1997-04-28 1998-06-16 Rosenbaum; Michael Dental etchant and process of using
SE514784C2 (sv) * 1998-08-17 2001-04-23 Mediteam Dental Ab Metod och preparat för rengöring av rotytor och omgivande vävnader hos tänder
JP2002187857A (ja) * 2000-12-20 2002-07-05 Gc Corp 初期齲蝕検知材
JP2002323493A (ja) * 2001-04-27 2002-11-08 Gc Corp 唾液緩衝能検査方法及び唾液緩衝能検査用具
JP2004205210A (ja) * 2001-12-14 2004-07-22 Gc Corp 齲蝕活性評価キット及び齲蝕活性評価用具
US20030113266A1 (en) * 2001-12-14 2003-06-19 Gc Corporation Material for evaluating dental caries activity

Similar Documents

Publication Publication Date Title
JP2008542225A5 (enExample)
BRPI0810524B8 (pt) derivado de (aza)indol, inibidor de xantina oxidase e composição farmacêutica compreendendo o dito derivado
WO2009009900A8 (en) Nucleic acid sequences for the amplification and detection of respiratory viruses
CY1110985T1 (el) Στοματικες συνθεσεις για απορροφηση των ενωσεων φωσφορου
JP5054002B2 (ja) 齲蝕組織を検出する歯科用組成物、検出方法
UY30610A1 (es) Moduladores de mglur5
NI200800227A (es) Acidos 1,3-dioxano carboxilicos
BRPI0706992C8 (pt) composto de fórmula (i) e formulação farmacêutica
BRPI0812317A2 (pt) Sais de ácido etilenodiamina dissuccínico, composição contendo os ditos sais, uso e método de preparação destes.
DK2025661T3 (da) Fluoralkyloxyholdige combretastatinderivater, fremstilling og anvendelse heraf
BR0318125A (pt) Derivados de benzeno trìmeros macrociclicamente substituìdos
EA200702352A1 (ru) Новые композиции нутрицевтиков
ATE548030T1 (de) Zusammensetzung mit langsamer freisetzung von fe salzen, verfahren zu ihrer herstellung und ihre verwendung
AR072103A1 (es) Derivados de (piperazinilo con enlaces puente)-1- alcanona, su utilizacion como inhibidores de p75 y composiciones farmaceuticas que los contienen
EA200801533A1 (ru) Производные антрахинона в качестве маркирующих веществ для жидкостей
DE502006008710D1 (de) Substituierte tetrahydroisochinoline als mmp-inhibitoren, verfahren zu ihrer herstellung und ihre verwendung als medikament
BRPI0514452A (pt) composições, métodos de fabricação e uso de compostos de guanilhidrazona
BRPI0713523A8 (pt) derivados de ácido fenilacético
ITRM20010456A0 (it) Procedimento per la preparazione di (r)- o (s)- amminocarnitina sale interno, dei suoi sali e dei suoi derivati.
TH96268A (th) ตัวยับยั้งการรวมกันของโปรตีน
BRPI0417003A (pt) uso de derivados de ácido pentadienóico para o tratamento de hiperuricemia
BR0109935A (pt) Sal de um derivado do ácido 5-amino salicìlico
Spencer et al. Haemolytic effects and changes in serum enzymes in normal rats exposed to halofantrine hydrochloride overdose
TH104141A (th) อนุพันธ์ 15,16-เมทิลีน-17-(1'-โพรพีนิล)-17-3'-ออกซิโดเอสตรา-4-อีน-3-โอน, การใช้อนุพันธ์ดังกล่าว และยาที่มีอนุพันธ์
UA137987U (uk) N-(3,4-ДИМЕТОКСИФЕНІЛ)-N<sup>1</sup>-(4<sup>1</sup>-ФТОРФЕНІЛ)-6-МОРФОЛІН-4-ІЛ-[1,3,5]ТРИАЗИН-2,4-ДІАМІН, ЩО ПРОЯВЛЯЄ АНТИВІРУСНУ АКТИВНІСТЬ ЩОДО ВІРУСІВ MIDDLE EAST CORONAVIRUS (HCОV-ЕМС) ТА АТИПОВОЇ ПНЕВМОНІЇ SARS